CVS Health Corporation (CVS) is listed on NYSE in the Healthcare sector Β· Healthcare Plans industry. The current price is 97.95, up 0.74% from the previous close. Market cap is approximately $125.3B.
The commentary below is auto-generated by comparing market data (P/E, ROE, D/E, etc.) against predefined thresholds. No LLM is used. This is not a buy/sell recommendation from us or any analyst. For reference only.
CVS's 25.84x P/E is in premium territory. Justifiable while growth accelerates, but this is also the band that reacts first to guidance cuts or macro shocks.
CVS's ROE at 6.21% lags the market. ROE stuck below 5% for 1-2 years can be a value trap signal β verify the fundamental story before assuming recovery.
CVS's D/E at 95.50 is on the high side. Credit rating, debt maturity ladder, and refinancing risk all become first-order considerations.
CVS Health Corporation is growing revenue at 7.10% annually. The interesting question is whether pricing power is lifting margins to compensate for the modest top-line.
CVS Health Corporation's 2.74% yield is standard. If the company is also buying back stock, evaluate on total shareholder return (dividends + buybacks) rather than yield alone.
Clinical trial outcomes, FDA decisions, and drug-pricing policy drive most of the short-term volatility.
CVS Health Corporation trades in the upper 31% of its 52-week range (69.51β110.68). The uptrend is intact, though how much optimism is already reflected in the price is a separate question worth checking.
Your watchlist and portfolio, one tap from your home screen β the Margin Call app
The stock moved within a 2.51% high-to-low band on the day, closing 0.74%. That falls within a typical intraday range.
CVS Health Corporation (CVS) is listed on NYSE, with recent volume of 1,790,949 shares. Volume is a supporting gauge of how much conviction sits behind a price move β the same gain reads differently on heavy versus light turnover.